ITOS — iTeos Therapeutics Share News
0.000.00%
Last trade - 00:00- $448.68m
- -$66.75m
- $35.00m
Brief: Iteos Announces Cash Runway Into 2026 Through Multiple Inflection Points Across Portfolio
Brief: Iteos Provides Business Updates And Clinical Development Plans For 2023
Brief: iTeos Therapeutics Inc Reports Q3 Earnings Per Share Of $0.03
Iteos Therapeutics Inc expected to post earnings of 10cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Coupa Software, Docusign
Brief: Iteos Therapeutics QTRLY Net Income Of $0.16 Per Basic Share And $ 0.15 Per Diluted Share
Brief: Iteos Therapeutics Q2 Earnings Per Share $0.15
Iteos Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Iteos Therapeutics Inc expected to post earnings of $1.20 a share - Earnings Preview
Several biotechs trading below cash position - Evercore ISI
Iteos Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: iTeos Therapeutics Says Cash Balance Provides Company Runway Into 2026
Brief: iTeos Reports First Quarter 2022 Financial Results
New class of cancer drugs down, not out, after Roche trial setback - analysts
New class of cancer drugs down, not out, after Roche trial setback - analysts
Roche's cancer drug failure weighs on companies developing similar drugs
Iteos Therapeutics Inc expected to post earnings of 80 cents a share - Earnings Preview
Iteos Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Iteos Reports Fourth Quarter And Full Year 2021 Results